%2520Sdn%2520Bhd_LOGO.png&w=3840&q=75){kind=logo}
Inno Therapeutics (M) Sdn Bhd
Inno Therapeutics — Innovating Tomorrow’s Drums, Vaccines & Cell Therapies
A Malaysia-based CMO/CDMO focused on drug, vaccine & cellular therapeutics research, development & scalable manufacturing.
Opportunities
What we’re looking for?
Regenerative Medicine & Cell Therapy
Estimated Budget
USD 100K~300K / year
Partnership Types
Product Distribution
CDMO / CMO
Co-Development / Joint R&D
Market Region
Asia Pacific
Supplier Qualification Requirements
Required Certifications
FDA
cGMP
cGMP
Manufacturing Requirements
FDA or clinical-trials proven products that produced in accredited cGMP facilities
Technical Documentation
MSDS and export documentation
More Detail
Own R&D team, patents and production in Taiwan
Company Overview
Inno Therapeutics (M) Sdn Bhd
Petaling Jaya, Malaysia
Advancing healthcare through innovative solutions in drug development, vaccine innovation, and cellular therapeutics. Delivering next-generation treatments and positioning Malaysia as a global leader in therapeutic innovation.
Established Since
2018
Annual Revenue
Under $10 million
Employees
10
Business Attribute
Manufacturer
Business Nature
Biotech/ Diagnostics/ Pharmaceutical/ Regenerative Medicine/ Preventive Medicine
Company Highlights
1
Full-Spectrum R&D & Manufacturing
Offering drug discovery, vaccine innovation, and cell therapy development with in-house GMP/CDMO capabilities.
2
Patient-Centric Innovation
Focus on unmet medical needs, including immune cell therapies, non-cell therapies, and transforming therapeutic access.
Market Presence
We covers major hospitals, clinics and wellness centers in Malaysia
Brands in Charge for Distribution
Allcell, Reyoung
Strategic Focus Areas
Biotechnology and regenerative medicine
Contact Info
Start the Conversation About Our Next Project
Thanks for your interest!
The 2025 section is now closed, but you can add this company to your wishlist. We’ll notify you the moment bookings open again.